The Combined Oxaliplatin Neurotoxicity Prevention Trial ( CONcePT ) tested intermittent oxaliplatin ( IO ) administration and the use of concurrent calcium and magnesium salts ( Ca/Mg ) , two modifications intended to reduce neurotoxicity and extend the duration of treatment .